[1]
Salahuddin et al. 2021. THE COMPARISON OF EFFICACY BETWEEN LOSARTAN AND DILTIAZEM AS ANTIPROTEINURIC AGENT IN NON-DIABETIC RENAL DISEASES. Journal of Ayub Medical College Abbottabad. 33, 3 (Jul. 2021), 492–495.